Novartis AG

Open: 103.83 Close: 103.46 Change: -0.37

The top 5 things about Novartis AG found by an AI.

This document will help you to evaluate Novartis AG without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, company, AG, MorphoSys, agree, business, develop, …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Swiss pharma company faces a substantial business risk in its supply chain.

Today's News

Novartis AG announced it has agreed to buy German biopharmaceutical company MorphoSys AG for 2.7 billion euros ($2.9 billion) The Swiss pharma company faces a substantial business risk in its supply chain. MorphoSys and Novartis agreed to take MorphoSYS private promptly after the Takeover Offer has been settled. Novartes seeks to obtain exclusive rights to develop and commercialize pelabresib and tulmimetostat. Novartis AG (0K9E.L) latest stock news & headlines - Yahoo Finance Home Mail News Finance Sports Entertainment Search Mobile More... Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company said it had submitted its own data to the FDA. Novartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology drug pelabresib to its pipeline. The company will pay $73-per-share for a total of $2.9 billion.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

How much time have you spent trying to decide whether investing in Novartis AG? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, company, AG, MorphoSys, agree, business, develop, and the most common words in the summary are: novartis, company, ag, market, statistic, job, morphosys, . One of the sentences in the summary was: Swiss pharma company faces a substantial business risk in its supply chain.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #company #ag #market #statistic #job #morphosys.